Back to top
more

Ligand Pharmaceuticals (LGND)

(Delayed Data from NSDQ)

$86.88 USD

86.88
213,105

+2.51 (2.97%)

Updated Jul 8, 2024 04:00 PM ET

After-Market: $86.88 0.00 (0.00%) 7:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 249)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Ligand Pharmaceuticals Incorporated falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 170 212 341 411 1,070
Receivables 39 35 92 59 42
Notes Receivable 0 0 0 0 0
Inventories 24 13 27 26 7
Other Current Assets 4 3 5 4 5
Total Current Assets 237 264 465 501 1,124
Net Property & Equipment 16 12 21 14 7
Investments & Advances 48 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 9 34 24 26
Intangibles 470 458 742 796 326
Deposits & Other Assets 6 5 3 4 2
Total Assets 787 763 1,298 1,362 1,495
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2 5 8 4 2
Current Portion Long-Term Debt 0 77 0 0 0
Current Portion Capital Leases 0 0 0 7 0
Accrued Expenses 12 16 18 19 10
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 0 14 69 5
Total Current Liabilities 17 99 42 100 17
Mortgages 0 0 0 0 0
Deferred Taxes/Income 33 31 59 65 33
Convertible Debt 0 0 321 442 639
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 31 25 39 40 29
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 86 165 476 653 728
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 199 148 373 318 367
Retained Earnings 503 451 449 392 400
Other Equity -1 -1 -1 -1 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 701 597 821 710 767
Total Liabilities & Shareholder's Equity 787 763 1,298 1,362 1,495
Total Common Equity 701 597 821 710 767
Shares Outstanding 17.30 16.80 16.70 16.00 17.50
Book Value Per Share 40.52 35.56 49.17 44.35 43.84

Fiscal Year End for Ligand Pharmaceuticals Incorporated falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 311 170 191 219
Receivables NA 28 39 36 28
Notes Receivable NA 0 0 0 0
Inventories NA 21 24 25 27
Other Current Assets NA 9 4 2 3
Total Current Assets NA 369 237 254 277
Net Property & Equipment NA 15 16 16 11
Investments & Advances NA 47 48 47 0
Other Non-Current Assets NA 66 0 0 0
Deferred Charges NA 0 0 9 9
Intangibles NA 397 470 425 442
Deposits & Other Assets NA 11 6 8 5
Total Assets NA 914 787 769 758
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 2 2 2 10
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 12 12 11 7
Income Taxes Payable NA 1 0 1 11
Other Current Liabilities NA 1 1 1 0
Total Current Liabilities NA 18 17 16 29
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 54 33 33 28
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 31 47 25
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 107 86 101 93
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 218 199 184 171
Retained Earnings NA 589 503 485 495
Other Equity NA -1 -1 -1 -1
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 807 701 668 665
Total Liabilities & Shareholder's Equity NA 914 787 769 758
Total Common Equity 0 807 701 668 665
Shares Outstanding 18.00 17.70 17.30 17.30 17.20
Book Value Per Share 0.00 45.57 40.52 38.61 38.66